Technology

Navigating technology and regulatory shifts in pharma revenue management.

The provider hopes that this option will be a solution to the state’s primary care physician shortage.

Commissioner Markary announced the plans alongside the results of a generative AI pilot for scientific reviewers.

The pharma tech company announced a deal with Starvision to roll out its services across the network over the next five years.

Blake Powers, CEO, medigi, explains how digital tools, AI, and automation are streamlining access to biosimilars and cell and gene therapies, signaling a shift toward more tech-enabled, patient-centric care.

Chip Parkinson, CEO, GiftHealth, explains how AI-powered data integration is bringing new hope to patients by revealing hidden access barriers, streamlining treatment pathways, and challenging outdated utilization management practices.

Capan discusses the collaboration between AWS and EVERSANA in the first part of this two-part interview.

Sheeran continues the conversation on the collaboration between AWS and EVERSANA in the second part of this interview.

AI is transforming content reviews to focus on relevant use, not just generation.

Ted Sweetser discusses turning information into usable datasets and pulling insights from them.

Ted Sweetser discusses how more accurate datasets are solving problems related to getting communities access to better healthcare.

Ted Sweetser discusses how the technology is providing greater insight into how marketing materials are being viewed.

How to maximize market-entry performance for new pharma products in an increasingly competitive launch environment.

Ted Sweetser discusses how the technology is expanding the amount of content that can be created.

Why a fundamental rethinking of how manufacturers engage with healthcare providers, payers, and patients is necessary in today's pharma landscape.

The Verseon CEO discusses how this advanced technology is helping to discover new drug candidates.

Davidi Vortman, CEO, UltraSight, discusses how AI-powered heart scan technology can help high-risk cardiovascular disease patients.

As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.

Hyfe’s CEO discusses the importance of DTx and how it can change the way certain conditions are treated.

Rahman discusses Google Gemini and what it could mean to the future of pharma commercialization and content development.

If used properly, AI can be a game-changer for drug development.

Key trends in healthcare communication to build trust between healthcare providers and their patients.

In an era where business-critical information is exchanged instantly, unsecured communication channels are a significant risk.

As coverage in Pharmaceutical Executive’s March issue reinforces, AI's connections and permutations are seemingly touching all parts of the industry—and only growing.